Join the Crohn's Disease - Maintenance group to help and get support from people like you.
Crohn's Disease - Maintenance News (Page 2)
Crohn's Disease: What Is It, and How Can It Be Treated?
THURSDAY, June 15, 2023 – Crohn's disease can turn your life into a gastrointestinal nightmare, but there is hope. According to the National Institute of Diabetes and Digestive and Kidney Diseases...
Crohn Disease More Common in People With Hidradenitis Suppurativa
WEDNESDAY, June 14, 2023 – Pediatric patients with hidradenitis suppurativa (HS) have a higher prevalence of Crohn disease, according to a research letter published online June 14 in JAMA...
Upadacitinib Superior to Placebo in Moderate-to-Severe Crohn Disease
WEDNESDAY, May 31, 2023 – For patients with moderate-to-severe Crohn disease, upadacitinib induction and maintenance treatment are superior to placebo, according to a study published in the May 25...
FDA Approves First Pill to Treat Moderate-to-Severe Crohn's Disease, Rinvoq (upadacitinib)
FRIDAY, May 19, 2023 – Patients with Crohn’s disease have a new treatment option, following U.S. Food and Drug Administration approval of a pill called Rinvoq (upadacitinib). Rinvoq is meant to t...
Small Increase in Lymphoma Risk Seen With Crohn Disease, Ulcerative Colitis
WEDNESDAY, May 10, 2023 – Crohn disease (CD) and ulcerative colitis (UC) are associated with a slightly increased risk for lymphoma, according to a study published online April 13 in Clinical...
Cardiovascular Fitness Tied to Lower IBD Risk in Children
TUESDAY, May 9, 2023 – Cardiovascular fitness may lower the risk for inflammatory bowel disease (IBD) in children and teens, according to a study published online May 1 in JAMA Pediatrics. Chun-Ying...
Household Factors Can Raise a Child's Odds for Inflammatory Bowel Disease
TUESDAY, May 9, 2023 – What puts kids at risk for pediatric inflammatory bowel disease (IBD) and what could help prevent it? A review of 36 observational studies that included 6.4 million kids...
Crohn's Disease: What It Is, Symptoms & Treatment
MONDAY, May 8, 2023 – Crohn’s disease, a type of inflammatory bowel disease, has no cure. But there are many treatments, specific to type, and it is possible to keep the symptoms under control. A g...
Two-Thirds of IBD Patients Partially, Fully Exclude One Food Category
FRIDAY, May 5, 2023 – Approximately two-thirds of patients with inflammatory bowel disease (IBD) report the partial or total exclusion of at least one food category, according to a study published...
FDA Approves Abrilada (adalimumab-afzb), a Biosimilar to Humira
November 18, 2019 - Pfizer Inc. (NYSE: PFE) today announced the United States (U.S.) Food and Drug Administration (FDA) has approved Abrilada™ (adalimumab-afzb), as a biosimilar to Humira® (a...
FDA Approves Ixifi (infliximab-qbtx), a Biosimilar to Remicade
December 13, 2017 – Pfizer Inc. (NYSE:PFE) announced today that the United States (U.S.) Food and Drug Administration (FDA) has approved Ixifi (PF-06438179, infliximab-qbtx), a chimeric...
FDA Approves Cyltezo (adalimumab-adbm), a Biosimilar to Humira
Ridgefield, Conn., August 29, 2017 – Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Cyltezo, a biosimilar to Humira, in a p...
FDA Approves Renflexis (infliximab-abda), a Biosimilar to Remicade
INCHEON, Korea – April 24, 2017 – Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved Renflexis (infliximab-abda), a biosimilar referencing Rem...
FDA Approves Amjevita (adalimumab-atto), a Biosimilar to Humira
September 23, 2016 – The U.S. Food and Drug Administration today approved Amjevita (adalimumab-atto) as a biosimilar to Humira (adalimumab) for multiple inflammatory diseases. Amjevita is approved...
Ask a question
To post your own question to this support group, sign in or create an account.